Faes Farma SA

FAE

Equity

ISIN ES0134950F36 / Valor 2837976

BME Bolsas y Mercados Espanoles - Renta Variable (2025-11-18)

EUR 4.60-0.22%

Faes Farma SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Faes Farma SA is a pharmaceutical company based in Leioa, Spain, with additional offices and subsidiaries in various countries around the world. The company is primarily focused on the research, development, manufacturing, and marketing of prescription medicines, healthcare products, and animal nutrition products. Faes Farma SA is actively engaged in the pharmaceutical industry, producing a range of products to meet the needs of healthcare professionals and consumers globally.

Summarized from source with an LLMView SourceSector: Healthcare

Pharmaceutical Business Growth

The pharmaceutical division saw a 9% increase, reaching €269 million. International markets contributed significantly with a 14% growth, while licenses grew by 13%, driven by the success of key molecules such as Bilastine, Calcifediol, and Mesalazine.

Strategic Acquisitions

Faes Farma strengthened its position in the ophthalmology market through strategic acquisitions, including the recent purchase of Edol in March. These moves have expanded the company's portfolio and facilitated direct entry into new European markets.

Dividend Distribution

The company approved a final dividend payment of €0.138 per share on July 7, culminating in a total dividend of €0.179 per share with a payout ratio of 51%, reflecting shareholder support and confidence in Faes Farma's strategic direction.

Ophthalmology Expansion

Ophthalmology remains a key growth area for Faes Farma, with expectations of double-digit growth. This focus aligns with the company's global strategy and enhances its international expansion efforts.

Summarized from source with an LLMView Source

Key figures

32.6%1Y

30.1%3Y

31.0%5Y

Performance

23.3%1Y

18.5%3Y

20.4%5Y

Volatility